MRD Monitoring in Acute Lymphoblastic Leukemia
0 意见
• 06/15/23
0
0
嵌入
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论